At a glance

ClinicalIndex Comparison Record

N/ACompleted· 104 enrolled

Drug / intervention

Flash glucose monitoring system +1 moredevice

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03522870

NCT03522870N/ACompleted

Compare CT.gov

Effects of Novel Flash Glucose Monitoring System on Glycemic Control in Adult Patients With Type 1 Diabetes Mellitus

Sun Yat-sen University·interventional·Posted May 11, 2018·Updated Feb 10, 2023

In Brief

A clinical study evaluating Flash glucose monitoring system and SMBG for Diabetes Mellitus, Type 1. Completed, enrolled 104 participants across 1 site.

Detailed Summary

This trial is a randomized, multi-center, parallel-group, efficacy and safety study with a 26-weeks follow- up(after 2-week recruitment). The study aims to: 1)compare the effects of novel flash glucose monitoring system (FGMS) and conventional Self Measurement of Blood Glucose (SMBG); and 2) optimize integrated management for glycaemic control in adult patients with type 1 diabetes who are sub-optimally controlled.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsDiabetes Mellitus, Type 1

CountriesChina

Collaborators--

Timeline

N/ACompletedFinished

20192020202120222023202420252026

Enrollment StartMay 2018

First PostedMay 2018

Primary CompletionJun 2022

TodayJul 2026

First PostedMay 11, 2018

Enrollment StartMay 1, 2018

Primary CompletionJun 19, 2022

TodayJul 2, 2026

Enrollment to primary: 4.1 yearsPosted 8.1 years ago

Interventions

Flash glucose monitoring systemdevice

Using flash glucose monitoring system continuously on Week 2-14 and Week 14-26

SMBGdevice

Performing SMBG at least three times/day on Week 2-14 and Week 14-26